NASDAQ:CELC

Celcuity - CELC Stock Forecast, Price & News

$9.36

-0.04 (-0.43%)

(As of 02/3/2023 10:46 AM ET)

Add

Compare

Today's Range: $9.27
▼
$9.52
50-Day Range: $7.55
▼
$14.01
52-Week Range: $4.81
▼
$14.40

Volume: 2,677 shs
Average Volume: 55,782 shs
Market Capitalization: $144.71 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $20.00

Institutional Ownership

Celcuity MarketRank™ Forecast

Analyst Rating: N/A
0.00 Rating Score
Upside/Downside: 112.8% Upside
$20.00 Price Target
Short Interest: Bearish
2.19% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$1.50 M Bought Last Quarter
Proj. Earnings Growth: Decreasing
From ($1.96) to ($1.98) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.41 out of 5 stars

Medical Sector

923rd out of 1,030 stocks

Medical Laboratories Industry

23rd out of 25 stocks

2.0

Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of $20.00, Celcuity has a forecasted upside of 112.8% from its current price of $9.40.
Amount of Analyst Coverage
Celcuity has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.19% of the float of Celcuity has been sold short.
Short Interest Ratio / Days to Cover
Celcuity has a short interest ratio ("days to cover") of 7.4.
Change versus previous month
Short interest in Celcuity has recently increased by 96.03%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Celcuity does not currently pay a dividend.
Dividend Growth
Celcuity does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CELC.

1.4

News and Social Media Coverage

News Sentiment
Celcuity has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Celcuity this week, compared to 1 article on an average week.
MarketBeat Follows
Only 2 people have added Celcuity to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Celcuity insiders have bought 44,904.41% more of their company's stock than they have sold. Specifically, they have bought $1,499,997.00 in company stock and sold $3,333.00 in company stock.
Percentage Held by Insiders
32.90% of the stock of Celcuity is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 31.05% of the stock of Celcuity is held by institutions.

0.0

Earnings and Valuation

Earnings Growth
Earnings for Celcuity are expected to decrease in the coming year, from ($1.96) to ($1.98) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Celcuity is -3.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Celcuity is -3.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Celcuity has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Celcuity (NASDAQ:CELC) Stock

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Receive CELC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celcuity and its competitors with MarketBeat's FREE daily newsletter.

CELC Stock News Headlines

December 15, 2022 | finance.yahoo.com

Bullish insiders bet US$1.6m on Celcuity Inc. (NASDAQ:CELC)

December 12, 2022 | finanznachrichten.de

Celcuity Inc.: Celcuity Closes $100 Million Private Placement

February 3, 2023 | Investing Trends (Ad)

The Humble Mineral at the Heart of the EV Revolution (Not Lithium)

You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!

December 12, 2022 | finance.yahoo.com

Celcuity Closes $100 Million Private Placement

December 9, 2022 | finance.yahoo.com

Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Patients with Advanced Breast Cancer at the 2022 San Antonio Breast Cancer Symposium

December 7, 2022 | finance.yahoo.com

Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib for the Treatment of HR+/HER2- Advanced Breast Cancer

November 22, 2022 | finance.yahoo.com

Celcuity to Present Additional Data for Gedatolisib at the 2022 San Antonio Breast Cancer Symposium

November 14, 2022 | seekingalpha.com

Celcuity Inc. (CELC) Q3 2022 Earnings Call Transcript

February 3, 2023 | Investing Trends (Ad)

The Humble Mineral at the Heart of the EV Revolution (Not Lithium)

November 10, 2022 | finance.yahoo.com

Celcuity Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 10, 2022 | finance.yahoo.com

Celcuity to Participate in the 13th Annual Craig-Hallum Alpha Select Conference

November 3, 2022 | finance.yahoo.com

Celcuity Inc. Schedules Release of Third Quarter 2022 Financial Results and Webcast/Conference Call

October 17, 2022 | finance.yahoo.com

Celcuity Inc. (CELC)

October 10, 2022 | reuters.com

CELC.O - Celcuity Inc | Stock Price & Latest News | Reuters

September 14, 2022 | benzinga.com

Celcuity (NASDAQ:CELC) – Celcuity Appoints Polly Murphy, D.V.M., Ph.D., to Board of Directors - Benzinga

September 14, 2022 | finance.yahoo.com

Celcuity Appoints Polly Murphy, D.V.M., Ph.D., to Board of Directors

August 22, 2022 | reuters.com

CELC.OQ - Celcuity Inc | Stock Price & Latest News | Reuters

August 17, 2022 | nasdaq.com

Is Celcuity (NASDAQ:CELC) Using Debt In A Risky Way? - Nasdaq

August 16, 2022 | finance.yahoo.com

What Is The Ownership Structure Like For Celcuity Inc. (NASDAQ:CELC)? - Yahoo Finance

August 15, 2022 | seekingalpha.com

Celcuity Inc. (CELC) CEO Brian Sullivan on Q2 2022 Results - Earnings Call Transcript

August 11, 2022 | benzinga.com

Celcuity: Q2 Earnings Insights - Benzinga

August 11, 2022 | seekingalpha.com

Celcuity GAAP EPS of -$0.55 (NASDAQ:CELC) - Seeking Alpha

August 11, 2022 | finance.yahoo.com

Celcuity Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 4, 2022 | benzinga.com

Celcuity Inc. Schedules Release of Second Quarter 2022 Financial Results and Webcast/Conference Call - Benzinga

August 4, 2022 | finance.yahoo.com

Celcuity Inc. Schedules Release of Second Quarter 2022 Financial Results and Webcast/Conference Call

August 3, 2022 | benzinga.com

Celcuity to Participate in the Canaccord Genuity 42nd Annual Growth Conference - Benzinga

August 3, 2022 | finance.yahoo.com

Celcuity to Participate in the Canaccord Genuity 42nd Annual Growth Conference

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CELC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celcuity and its competitors with MarketBeat's FREE daily newsletter.

CELC Company Calendar

Last Earnings: 11/10/2022
Today: 2/03/2023
Next Earnings (Estimated): 3/22/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:CELC
CUSIP: N/A
CIK: 1603454
Web: www.celcuity.com
Phone: (763) 392-0767
Fax: N/A
Employees: 39
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $20.00
High Stock Price Forecast: $20.00
Low Stock Price Forecast: $20.00
Forecasted Upside/Downside: +113.7%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.40)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,600,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -62.64%
Return on Assets: -46.85%

Debt

Debt-to-Equity Ratio: 0.34
Current Ratio: 9.74
Quick Ratio: 9.74

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.61 per share
Price / Book: 2.03

Miscellaneous

Outstanding Shares: 15,460,000
Free Float: 10,374,000
Market Cap: $144.71 million
Optionable: Not Optionable
Beta: 0.66

Key Executives

Brian F. Sullivan
Chairman & Chief Executive Officer

Vicky Hahne
Chief Financial Officer

Lance G. Laing
Secretary, Director & Chief Science Officer

Arthur P. DeCillis
Chief Medical Officer

Sheri Smith
Head-Clinical Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CELC Stock - Frequently Asked Questions

What is Celcuity's stock price forecast for 2023?: 0 equities research analysts have issued 1-year target prices for Celcuity's shares. Their CELC share price forecasts range from $20.00 to $20.00. On average, they predict the company's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 112.8% from the stock's current price.
View analysts price targets for CELC or view top-rated stocks among Wall Street analysts.
How have CELC shares performed in 2023?: Celcuity's stock was trading at $14.01 at the beginning of the year. Since then, CELC shares have decreased by 32.9% and is now trading at $9.40.
View the best growth stocks for 2023 here.
Are investors shorting Celcuity?: Celcuity saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 202,700 shares, an increase of 96.0% from the December 31st total of 103,400 shares. Based on an average daily trading volume, of 27,400 shares, the days-to-cover ratio is presently 7.4 days. Currently, 2.2% of the company's stock are sold short.
View Celcuity's Short Interest.
When is Celcuity's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 22nd 2023.
View our CELC earnings forecast.
How were Celcuity's earnings last quarter?: Celcuity Inc. (NASDAQ:CELC) posted its quarterly earnings results on Thursday, November, 10th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by $0.26.
What other stocks do shareholders of Celcuity own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Celcuity investors own include Bank of Hawaii (BOH), InterDigital (IDCC), STAG Industrial (STAG), Evoke Pharma (EVOK), Amicus Therapeutics (FOLD), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Genocea Biosciences (GNCA), Idera Pharmaceuticals (IDRA) and Ovid Therapeutics (OVID).

When did Celcuity IPO?: (CELC) raised $18 million in an initial public offering (IPO) on Wednesday, September 20th 2017. The company issued 2,000,000 shares at a price of $8.00-$10.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO.
What is Celcuity's stock symbol?: Celcuity trades on the NASDAQ under the ticker symbol "CELC."
Who are Celcuity's major shareholders?: Celcuity's stock is owned by a variety of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Brian F Sullivan, Richard E Buller and Richard Nigon.
View institutional ownership trends.
How do I buy shares of Celcuity?: Shares of CELC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Celcuity's stock price today?: One share of CELC stock can currently be purchased for approximately $9.40.
How much money does Celcuity make?: Celcuity (NASDAQ:CELC) has a market capitalization of $145.32 million. The company earns $-29,600,000.00 in net income (profit) each year or ($2.40) on an earnings per share basis.
How can I contact Celcuity?: Celcuity's mailing address is 16305 36TH AVENUE NORTH SUITE 100, MINNEAPOLIS MN, 55446. The official website for the company is www.celcuity.com. The company can be reached via phone at (763) 392-0767.

This page (NASDAQ:CELC) was last updated on 2/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Celcuity - CELC Stock Forecast, Price & News

Celcuity MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Celcuity (NASDAQ:CELC) Stock

CELC Stock News Headlines

CELC Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

CELC Stock - Frequently Asked Questions

Overall MarketRank^™